Actively Recruiting
Combined Injury-site & Lumbosacral Epidural Spinal Cord Stimulation
Led by The University of Hong Kong · Updated on 2025-12-01
5
Participants Needed
1
Research Sites
182 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Spinal cord stimulation (SCS) has been shown in previous studies to be capable of restoring motor and autonomic function in patients with chronic complete spinal cord injury (SCI). Clinical studies have demonstrated that SCS enables activation of previously paralyzed muscles, leading to functional improvements in patients in the chronic stage of paralysis through the delivery of activity-based interventions. For most previous studies on SCS in SCI, stimulation was invariably applied to lumbrosacral plexus only. In this study, after signing the consent form, the patient will be assigned for standard surgery with additional implant of the spinal cord stimulator. The investigators propose to conduct the SCS with three phases. For the first phase, SCS over lumbrosacral spinal cord will be activated for 3 months with appropriate stimulation of lower limb muscles for walking together with physiotherapy of individual muscle groups for walking. For the second phase, SCS over lumbrosacral spinal cord will be stopped. SCS over the injury site will be activated for 3 months with appropriate stimulation of lower limb muscles. For the third phase, SCS over both lumbrosacral spinal cord and injury site of spinal cord will be activated for another 3 months with appropriate stimulation of lower limb muscles.
CONDITIONS
Official Title
Combined Injury-site & Lumbosacral Epidural Spinal Cord Stimulation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- American Society of Anesthesiologist (ASA) status I-III
- Age between 18 and 70 years old
- Patients with spinal cord injury for more than 2 years
- Traumatic or atraumatic spinal cord injury
- American Spinal Injury Association (ASIA) Impairment Scale A or B
- Have previous MRI documenting extent of spinal cord injury before recruitment
You will not qualify if you...
- Chronic opioid user
- Presence of chronic pain condition lasting over 3 months
- Alcohol or substance abuse
- Active and untreated psychiatric diseases
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Queen Mary Hospital
Hong Kong, Hong Kong
Actively Recruiting
Research Team
T
Timmy CW Chan, MBBS
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here